Related Experiment Video
Updated: Jul 8, 2026
Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
Does global gene expression analysis in type 2 diabetes provide an opportunity to identify highly promising drug
1Department of Internal Medicine I, University Hospital of Regensburg, D-93042 Regensburg, Germany. christa.buechler@klinik.uni-regensburg.de
Abstract:
The recent technological advances in high-throughput gene expression analysis allow the simultaneous investigation of thousands of genes. These technologies represent promising tools for the identification of new drug targets and considerable progress has been achieved in cancer research where microarray data provide a basis to design new drugs and to predict adverse reactions and the efficacy of chemotherapy. The metabolic syndrome represents a cluster of disorders including high blood pressure, insulin resistance/type 2 diabetes mellitus, visceral obesity and dyslipidaemia with fatty liver disease being a common associated complication. High-throughput gene expression analyses using GeneChips, microarrays and serial analysis of gene expression (SAGE) have been applied to study global gene expression in insulin resistance/type 2 diabetes mellitus. Type 2 diabetes mellitus is a multifactorial and polygenic disease by which several organs are affected. Therefore, the identification of both, disease causing and therapeutically relevant target genes is an ambitious challenge. In the present review we focus on genomic approaches that used biopsies from human skeletal muscle, liver and adipose tissue, the main organs affected by insulin resistance. Members of the PPARgamma coactivator-1 (PGC-1) family of transcriptional coactivators are decreased in skeletal muscle in insulin resistance accounting for the reduced expression of genes involved in mitochondrial oxidative phosphorylation. Hepatic steatosis is also linked to alterations in mitochondrial phosphorylation and oxidative metabolism. An up regulation of pro-inflammatory genes can be detected in early stages of fatty liver disease without histological signs of inflammation. Impaired adipogenesis, intra-adipose accumulation of macrophages and a sustained release of inflammatory and acute phase proteins are characteristic features of adipose tissue in obesity and may aggravate systemic insulin resistance.
Insights
High-throughput gene expression analysis aids in understanding metabolic syndrome, a cluster of conditions including insulin resistance and type 2 diabetes. Genomic approaches reveal key gene expression changes in affected tissues, offering insights into disease mechanisms and potential drug targets.
Area of Science:
- Genomics
- Molecular Biology
- Metabolic Disorders
Background:
- Technological advances enable simultaneous investigation of thousands of genes.
- High-throughput gene expression analysis is crucial for identifying drug targets and predicting treatment outcomes in diseases like cancer.
- Metabolic syndrome, characterized by insulin resistance, obesity, and fatty liver disease, affects multiple organs and presents a complex challenge for gene identification.
Purpose of the Study:
- To review genomic approaches for studying global gene expression in insulin resistance and type 2 diabetes mellitus.
- To focus on gene expression in skeletal muscle, liver, and adipose tissue, key organs affected by insulin resistance.
- To identify disease-causing and therapeutically relevant target genes.
Main Methods:
- Utilized high-throughput gene expression analyses including GeneChips, microarrays, and serial analysis of gene expression (SAGE).
- Focused on genomic approaches using biopsies from human skeletal muscle, liver, and adipose tissue.
- Reviewed alterations in gene expression related to mitochondrial function, inflammation, and adipogenesis.
Main Results:
- Decreased PPARgamma coactivator-1 (PGC-1) family members in skeletal muscle correlate with reduced expression of mitochondrial oxidative phosphorylation genes.
- Hepatic steatosis is associated with altered mitochondrial phosphorylation and oxidative metabolism.
- Early-stage fatty liver disease shows upregulated pro-inflammatory genes, and adipose tissue in obesity exhibits impaired adipogenesis and macrophage accumulation, exacerbating insulin resistance.
Conclusions:
- Genomic approaches provide valuable insights into the molecular mechanisms underlying metabolic syndrome and insulin resistance.
- Identification of specific gene expression patterns in affected tissues can guide the development of novel therapeutic strategies.
- Understanding these complex gene interactions is critical for tackling multifactorial diseases like type 2 diabetes mellitus.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
01:26Type II Diabetes I: Introduction
01:22Diabetes Mellitus: Type 2 and Gestational
01:24Type II Diabetes II: Pathophysiology
01:26Type I Diabetes II: Pathophysiology
01:36Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...